Afatinib treatment of a squamous lung cancer after tumor progression of nivolumab.

Afatinib treatment of a squamous lung cancer after tumor progression of nivolumab.

Thorac Cancer. 2017 Oct 13;:

Authors: Jin Y, Jiang Q, Xin T

Abstract
Nivolumab prolonged disease control in a patient with advanced squamous lung cancer that was refractory to multiple treatments. The rapid eradication of cancer after the administration of nivolumab caused hemoptysis and repeated infection. Six months after immunotherapy, mediastinal lymph node metastasis developed and afatinib effectively relieved dysphonia associated with nerve paralysis.

PMID: 29027754 [PubMed - as supplied by publisher]

from #ENT-PubMed via ola Kala on Inoreader http://ift.tt/2xHasWZ